DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Jander S, Turowski B, Kieseier BC et al.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Multiple Sclerosis Journal 2012;
18: 1650-1652
We do not assume any responsibility for the contents of the web pages of other providers.